Evidence map›Paper›PMID 41766715›Full record

ArticleTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2026

Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis.

Jakob Leonhardi, Tihomir Dermendzhiev, Enrica Bach, Mandy Brückner, Song-Yau Wang, Georg-Nikolaus Franke, Madlen Jentzsch, Simone Heyn, Klaus H Metzeler, Uwe Platzbecker and 4 more

Abstract read
In one paragraph

Article in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jakob LeonhardiDepartment of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.
Tihomir DermendzhievDepartment of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.
Enrica BachLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Mandy BrücknerLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Song-Yau WangLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Georg-Nikolaus FrankeLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Madlen JentzschLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Simone HeynLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Klaus H MetzelerLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Uwe PlatzbeckerLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Timm DeneckeDepartment of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.
Maximilan MerzLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Vladan VučinićLeipzig University Medical Center, Clinic and Policlinic for Hematology, Cellular Therapy, Hemostaseology and Infective Diseases, Leipzig, Germany.
Hans-Jonas MeyerDepartment of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Peripheral stem-cell collection is an essential step/prerequisite for high-dose treatment of patients with multiple myeloma (MM). Radiomics provides numerous analytic parameters from imaging modalities and can characterize tissues in a quantitative manner. The present study used radiomics derived parameters based on computed tomography (CT) images to identify prognostic factors for stem-cell mobilization in patients with MM. Methods: Between May 2020 and September 2022 all patients who had undergone quadruplet induction therapy, were scheduled for stem-cell mobilization in preparation for autologous stem cell transplantation, and had CT scans prior to chemomobilization were retrospectively analyzed. Total 34 patients (25 males [74%], median age 60 ± 8 years) were analyzed. Whole-body CT images routinely obtained before the start of mobilization were analyzed with texture analysis. Results: Of the investigated CT radiomics features, three CT textures were associated with the concentration of CD34+ cell count in peripheral blood at begin of apheresis. The second-order texture feature "S(1,0)AngScMom" and the wavelet transform feature "WavEnHH_s-5" were positively correlated ( Conclusion: CT radiomics features can predict apheresis yield in patients undergoing hematopoietic cell mobilization in patients with MM. Further analyses are needed to validate the identified radiomics signature in clinical routine and to test the predictive abilities.

Indexed as

Computed tomographyHematopoietic cell mobilizationMultiple myelomaRadiomics

Identifiers

PMID41766715
PMCPMC12948403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.